Effect of Intravenous Iron Sucrose on Oxidative Stress in Peritoneal Dialysis Patients

REFERENCES

• Locatelli F, Canaud B, Eckardt KU, Stenvinkel P, Wanner C, Zoccali C. Oxidative stres in end-stage renal disease: An emerging threat to patient outcome. Nephrol Dial Transplant. 2003; 18: 1272–1280
   PubMed Web of Science ®Google Scholar
• Galle J. Oxidative stres in chronic renal failure. Nephrol Dial Transplant. 2001; 16: 2135–2137
   PubMed Web of Science ®Google Scholar
• Epperlein MM, Nourooz-Zadeh J, Jayasena SD, et al. Nature and biological significance of free radicals generated during bicarbonate hemodialysis. J Am Soc Nephrol. 1998; 9: 457–463
   PubMedGoogle Scholar
• Camsari T, Cavdar C, Ozture H, Onvural B, Semin I, Celik A, et al. Effects of conventional heparin and low-molecular-weight heparin treatment on lipid metabolism during a single hemodialysis session. Nephron. 1999; 82(3)286–288
   PubMedGoogle Scholar
• Rousselot DB, Jaudon MC, Issad B, Cacoub P, Congy F, Jardel C. Antioxidant status of elderly chronic renal patients treated by continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 1997; 12: 1399–1405
   PubMedGoogle Scholar
• Özden M, Maral H, Akaydýn D, Çetinalp P, Kalender B. Erythrocyte glutathione peroxidase activity, plasma malondialdehyde and erythrocyte glutathione levels in hemodialysis and CAPD patients. Clin Biochem. 2002; 35(4)269–273
   PubMed Web of Science ®Google Scholar
• Ross EA, Koo LC, Moberly JB. Low whole blood erythrocyte levels of glutathione in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis. 1997; 30(4)489–494
   PubMedGoogle Scholar
• Hsu CY, McCulloch CE, Curhan GC. Epidemiology of anemia associated with chronic renal insufficiency among adults in the United States: Results from the Third National Health and Nutrition Examination Survey. J Am Soc Nephrol. 2002; 13: 504–510
   PubMed Web of Science ®Google Scholar
• Agarwal R, Vasavada N, Sachs N, Chase S. Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease. Kidney Int. 2004; 65: 2279–2289
   PubMed Web of Science ®Google Scholar
• Lim S, Wei Y, Yu Leng, Kho B. Enhanced oxidative stress in hemodialysis patients receiving intravenous iron therapy. Nephrol Dial Transplant. 1999; 14: 2680–2687
   PubMed Web of Science ®Google Scholar
• Roob M, Khoschsorur G, Tiran A, Horina J, Holzer H, Winklhofer-Roob M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J Am Soc Nephrol. 2000; 11: 539–549
   PubMed Web of Science ®Google Scholar
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis. Jan, 2001; 37(1 Suppl. 1)S182–S238
   PubMed Web of Science ®Google Scholar
• Sun Yi, Oberley L, Li Ying. A simple method for clinical assay of SOD. Clin Chem. 1988; 3413: 497–500
   Google Scholar
• Stocks J, Dormandy TL. Autooxidation of human red cell lipids induced by hydrogen peroxide. Br J Hematology. 1971; 20: 95–111
   PubMed Web of Science ®Google Scholar
• Macdougall I. Intravenous administration of iron in epoetin treated hemodialysis patients—which drugs, which regimen?. Nephrol Dial Transplant. 2000; 15: 1743–1745
   PubMedGoogle Scholar
• Clermont G, Lecour S, Lahet JJ, Siohan P, Vergely C, Chevet D, et al. Alteration in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: A possible explanation for the increased cardiovascular risk in these patients. Cardiovascular Research. 2000; 47: 618–623
   PubMed Web of Science ®Google Scholar
• Gali F, Rovidati S, Benedetti S, Buoncristiani U, Covarelli C, Floridi A, et al. Overexpression of erythrocyte glutathione S-transferase in uremia and dialysis. Clin Chem. 1999; 45(10)1781–1788
   PubMedGoogle Scholar
• Bolton C, Downs LG, Victory JG, Dwight JV, Tomson C, Mackness MI, et al. Endothelial dysfunction in chronic renal failure. Roles of lipoprotein oxidation and pro-inflammatory cytokines. Nephrol Dial Transplant. 2001; 16: 1189–1197
   PubMed Web of Science ®Google Scholar
• Lim PS, Chang YM, Thien YM, Wang NP, Yang CC, Chen TT, et al. 8- Isoprostaglandin F2- as a useful clinical biomarkers of oxidative stress in ESRD patients. Blood Purif. 2002; 20: 537–542
   PubMed Web of Science ®Google Scholar
• Rudko I, Balashova T, Ermolenko V. The role of lipid peroxidation and Na+- H+ exchange in the membranoprotective action of erythropoietin. Bio- News Scientific NR. 1993; 28: 5–41
   Google Scholar
• Cavdar C, Camsari T, Semin I, Gönenç S, Açýkgöz O. Lipid peroxidation and antioxidant activity in chronic haemodialysis patients treated with recombinant human erythropoietin. Scand J Urol Nephrol. 1997; 31: 371–375
   PubMed Web of Science ®Google Scholar
• Klahr S, Amico GD. Second International Symposium on Lipids, Atherosclerosis, and the Kidney: Summary of scientific presentations. Nephrol Dial Transplant. 1994; 9: 1660–1663
   PubMedGoogle Scholar
• Lim S, Vaziri N. The effects of iron dextran on the oxidative stress in cardiovascular tissues of rats with chronic renal failure. Kidney Int. 2004; 65: 1802–1809
   PubMedGoogle Scholar
• Fishbane S, John K, Muesaka K, Mittal S. Is there material hazard to treatment with intravenous iron?. Nephrol Dial Transplant. 1999; 14: 2595–2598
   PubMedGoogle Scholar
• Cavdar C, Temiz A, Yenicerioglu Y, Caliskan S, Celik A, Sifil A, et al. The effects of intravenous iron treatment on oxidant stress and erythrocyte deformability in hemodialysis patients. Scand J Urol Nephrol. 2003; 37: 77–82
   PubMed Web of Science ®Google Scholar
• Cighetti G, Duca L, Bortone L, Sala S, Nava I, et al. Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest 2002; 23(1)55–60
   Google Scholar
• Gaenzer H, Marschang P, Sturm W, Neumayr G, Vogel W, Patsch J, Weiss G. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol. 2002; 18(40(12))2189–2194
   Google Scholar
• Reddi A, Bollineni J, Baskin S, Nimmagadda V, Baker H. Serum ferritin and oxidative stress in patients undergoing hemodialysis. Nephron. 2000; 86: 202–203
   PubMedGoogle Scholar
• Danielson BG, Salmonson T, Derendorf H, Geisser P. Pharmacokinetics of ironhydroxide sucrose complex after a single intravenous dose in healthy volunteers. Arneimittelforschung. 1996; 46(6)615–621
   PubMedGoogle Scholar
• Jensen HS. C reactive protein. Ugeskr Laeger. 2000; 162(17)2453–2456
   PubMedGoogle Scholar